133 related articles for article (PubMed ID: 21384742)
21. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications.
Martín-Gallán P; Carrascosa A; Gussinyé M; Domínguez C
Free Radic Biol Med; 2003 Jun; 34(12):1563-74. PubMed ID: 12788476
[TBL] [Abstract][Full Text] [Related]
22. Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes.
Berg TJ; Snorgaard O; Faber J; Torjesen PA; Hildebrandt P; Mehlsen J; Hanssen KF
Diabetes Care; 1999 Jul; 22(7):1186-90. PubMed ID: 10388987
[TBL] [Abstract][Full Text] [Related]
23. Possible relevance of lipid peroxidation and thromboxane production to the initiation and/or evolution of microangiopathy in non-hyperlipidemic type 2 diabetes mellitus.
Katoh K
Diabetes Res Clin Pract; 1992 Nov; 18(2):89-98. PubMed ID: 1478157
[TBL] [Abstract][Full Text] [Related]
24. The Glycated Albumin (GA) to HbA1c Ratio Reflects Shorter-Term Glycemic Control than GA: Analysis of Patients with Fulminant Type 1 Diabetes.
Koga M; Inada S; Nakao T; Kawamori R; Kasayama S
J Clin Lab Anal; 2017 Jan; 31(1):. PubMed ID: 27386821
[TBL] [Abstract][Full Text] [Related]
25. Advanced glycation end products in hemodialyzed patients with diabetes mellitus correlate with leptin and leptin/body fat ratio.
Kalousová M; Sulková S; Zima T; Deppisch R; Beck W; Bednárová sV; Fortová M; Tesar V
Ren Fail; 2003 Mar; 25(2):277-86. PubMed ID: 12739834
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of glycated albumin (GA) and GA/HbA1c ratio for diagnosis of diabetes and glycemic control: A comprehensive review.
Yazdanpanah S; Rabiee M; Tahriri M; Abdolrahim M; Rajab A; Jazayeri HE; Tayebi L
Crit Rev Clin Lab Sci; 2017 Jun; 54(4):219-232. PubMed ID: 28393586
[TBL] [Abstract][Full Text] [Related]
27. Small- and large-fiber neuropathy after 40 years of type 1 diabetes: associations with glycemic control and advanced protein glycation: the Oslo Study.
Sveen KA; Karimé B; Jørum E; Mellgren SI; Fagerland MW; Monnier VM; Dahl-Jørgensen K; Hanssen KF
Diabetes Care; 2013 Nov; 36(11):3712-7. PubMed ID: 24026557
[TBL] [Abstract][Full Text] [Related]
28. [Biological variation of glycation and mean blood glucose have greater influence on Hba1c levels in type 1 young diabetic patients than glucose instability].
Abourazzak S; Dorchy H; Willems D; Melot C
Rev Med Brux; 2010; 31(2 Suppl):S55-64. PubMed ID: 21812216
[TBL] [Abstract][Full Text] [Related]
29. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.
Tan KC; Shiu SW; Chow WS; Leng L; Bucala R; Betteridge DJ
Diabetologia; 2006 Nov; 49(11):2756-62. PubMed ID: 16969649
[TBL] [Abstract][Full Text] [Related]
30. Advanced glycation end products, measured in skin, vs. HbA1c in children with type 1 diabetes mellitus.
Banser A; Naafs JC; Hoorweg-Nijman JJ; van de Garde EM; van der Vorst MM
Pediatr Diabetes; 2016 Sep; 17(6):426-32. PubMed ID: 26332801
[TBL] [Abstract][Full Text] [Related]
31. Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitus.
Berg TJ; Bangstad HJ; Torjesen PA; Osterby R; Bucala R; Hanssen KF
Metabolism; 1997 Jun; 46(6):661-5. PubMed ID: 9186302
[TBL] [Abstract][Full Text] [Related]
32. [Indicators of glycemic control --hemoglobin A1c (HbA1c), glycated albumin (GA), and 1,5-anhydroglucitol (1,5-AG)].
Sato A
Rinsho Byori; 2014 Jan; 62(1):45-52. PubMed ID: 24724426
[TBL] [Abstract][Full Text] [Related]
33. Glycated Albumin versus Glycated Hemoglobin as a Glycemic Indicator in Diabetic Patients on Peritoneal Dialysis.
Kobayashi H; Abe M; Yoshida Y; Suzuki H; Maruyama N; Okada K
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27120597
[TBL] [Abstract][Full Text] [Related]
34. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes.
Yoshiuchi K; Matsuhisa M; Katakami N; Nakatani Y; Sakamoto K; Matsuoka T; Umayahara Y; Kosugi K; Kaneto H; Yamasaki Y; Hori M
Endocr J; 2008 Jul; 55(3):503-7. PubMed ID: 18445997
[TBL] [Abstract][Full Text] [Related]
35. Glycated albumin in diabetic patients with chronic kidney disease.
Zheng CM; Ma WY; Wu CC; Lu KC
Clin Chim Acta; 2012 Oct; 413(19-20):1555-61. PubMed ID: 22579765
[TBL] [Abstract][Full Text] [Related]
36. Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and nepsilon-(carboxymethyl)lysine ELISA.
Galler A; Müller G; Schinzel R; Kratzsch J; Kiess W; Münch G
Diabetes Care; 2003 Sep; 26(9):2609-15. PubMed ID: 12941727
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
[TBL] [Abstract][Full Text] [Related]
38. Calculation of HbA1c and glycated albumin from serially measured self-monitored blood glucose in patients with type 1 diabetes mellitus.
Koga M; Suzuki S; Matsuo K; Tanahashi Y; Azuma H; Kasayama S
Clin Chim Acta; 2013 Oct; 425():188-91. PubMed ID: 23933122
[TBL] [Abstract][Full Text] [Related]
39. Hemoglobin A
Chan CL; Hope E; Thurston J; Vigers T; Pyle L; Zeitler PS; Nadeau KJ
Diabetes Care; 2018 Jul; 41(7):1406-1413. PubMed ID: 29674323
[TBL] [Abstract][Full Text] [Related]
40. Distinct associations of HbA1c and the urinary excretion of pentosidine, an advanced glycosylation end-product, with markers of endothelial function in insulin-dependent diabetes mellitus.
Smulders RA; Stehouwer CD; Schalkwijk CG; Donker AJ; van Hinsbergh VW; TeKoppele JM
Thromb Haemost; 1998 Jul; 80(1):52-7. PubMed ID: 9684785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
